The predictive value of 18F-FDG-PET to demonstrate disease activity in patients with relapsed multiple myeloma; a pilot study
Completed
- Conditions
- Kahler's disease10018865
- Registration Number
- NL-OMON32803
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
Relapsed multiple myeloma patients that demonstrate increased disease activity
Exclusion Criteria
-Ineligible to perform a scan
-Age <18 years.
-Pregnancy.
-Severe kidney dysfunction; serum-creatinine >=250 µM.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>- To define the increase of FDG-PET uptake in relapsed MM in comparison to SRS<br /><br>and X-ray examination.<br /><br></p><br>
- Secondary Outcome Measures
Name Time Method <p>Not applicable</p><br>